{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:34:06Z","timestamp":1794332046993,"version":"4.9.0"},"reference-count":34,"publisher":"Informa UK Limited","issue":"14","license":[{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Bristol Myers Squibb"},{"name":"Bristol Myers Squibb"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2025,6,9]]},"DOI":"10.1080\/14796694.2025.2501920","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T05:15:15Z","timestamp":1746854115000},"page":"1761-1769","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":17,"title":["EXCALIBER-RRMM: a phase III trial of iberdomide, daratumumab, and dexamethasone in relapsed\/refractory multiple myeloma"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8322-9323","authenticated-orcid":false,"given":"Sagar","family":"Lonial","sequence":"first","affiliation":[{"name":"Emory University","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8990-3254","authenticated-orcid":false,"given":"Meletios A.","family":"Dimopoulos","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens","place":["Athens, Greece"]},{"name":"Korea University","place":["Seoul, South Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus G.","family":"Berdeja","sequence":"additional","affiliation":[{"name":"Greco-Hainsworth Center for Research, Tennessee Oncology","place":["Nashville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7426-8865","authenticated-orcid":false,"given":"Paul G.","family":"Richardson","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4796-3352","authenticated-orcid":false,"given":"Hang","family":"Quach","sequence":"additional","affiliation":[{"name":"University of Melbourne","place":["Melbourne, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5236-7785","authenticated-orcid":false,"given":"Paula","family":"Rodr\u00edguez-Otero","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Universidad de Navarra, CIMA, IDISNA, CIBERONC","place":["Pamplona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1172-9772","authenticated-orcid":false,"given":"Paulo","family":"Maciag","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb","place":["Princeton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Hong","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb","place":["Princeton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Amatangelo","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb","place":["Princeton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb","place":["Princeton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7445-2603","authenticated-orcid":false,"given":"Niels W.C.J.","family":"van de Donk","sequence":"additional","affiliation":[{"name":"Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Cancer Center Amsterdam","place":["Amsterdam, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,5,10]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27422"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.117176"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10787-5"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.282905"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2021.100808"},{"key":"e_1_3_6_8_1","unstructured":"National Cancer Institute: surveillance epidemiology and end results program. Cancer Stat Facts: Myeloma; [cited 2025 Mar 20]. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-358812"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14213"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2020.1800451"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.add7574"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b01921"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-126146"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.66"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0620-8"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-113383"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-137667"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-137710"},{"key":"e_1_3_6_20_1","volume-title":"Poster session presented at: 61st Annual Meeting and Exposition of the American Society of Hematology","author":"Lonial S","year":"2019","unstructured":"Lonial S, Amatangelo M, Popat R, et al. Preclinical, translational, and clinical evidence of a differentiated profile for the novel CELMoD, iberdomide (CC-220). Poster session presented at: 61st Annual Meeting and Exposition of the American Society of Hematology; 2019 Dec 7\u201310; Orlando, FL."},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(21)02087-5"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00290-3"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101571"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00371"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123233"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1144056"},{"key":"e_1_3_6_27_1","unstructured":"International Myeloma Foundation [Internet]. A historic turning point: ODAC unanimously votes in favor of MRD testing as an early endpoint in myeloma clinical trials to support accelerated approvals of new treatments. 2024 Apr 18 [cited 2025 Mar 20] Available from: https:\/\/www.myeloma.org\/blog\/dr-duries\/odac-unanimously-in-favor-mrd-testing-early-endpoint-myeloma"},{"key":"e_1_3_6_28_1","volume-title":"2024 Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement","author":"US Food and Drug Administration","year":"2024","unstructured":"US Food and Drug Administration. In: 2024 Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement; 2024 Apr 12 [cited 2025 Mar 20] Available from https:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/april-12-2024-meeting-oncologic-drugs-advisory-committee-meeting-announcement-04122024"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-568907"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002827"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21228"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21265"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30206-6"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2023.107300"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0141-0"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.09.625"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2025.2501920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:10:47Z","timestamp":1773303047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2025.2501920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":34,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,6,9]]}},"alternative-id":["10.1080\/14796694.2025.2501920"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2025.2501920","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-03-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}